Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.59 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.54 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 3/20 | 0.52 |
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4118556 | 0.89 | NPC1 (0.62) | MAPTMEN1KMT2AKDM4ENPC1 | |
| SCHEMBL21750396 | 0.84 | PTPN11 (0.49) | LOXL2CYP4A11CYP4F2CA1CA2 | |
| SCHEMBL6538872 | 0.83 | LOXL2 (0.61) | LOXL2CYP4A11CYP4F2CA1CA2 | |
| SCHEMBL6716160 | 0.82 | CYP4A11 (0.60) | LOXL2CYP4A11CYP4F2CA1CA2 | |
| SCHEMBL3967293 | 0.82 | CA1 (0.58) | CA1CA2TDP1CA12CA7 | |
| SCHEMBL13898526 | 0.81 | CA12 (0.47) | LOXL2CYP4A11CYP4F2CA1CA2 | |
| SCHEMBL935888 | 0.81 | CA12 (0.47) | LOXL2CYP4A11CYP4F2CA1CA2 | |
| SCHEMBL6877770 | 0.81 | LOXL2 (0.59) | LOXL2CYP4A11CYP4F2CA1CA2 | |
| SCHEMBL1368363 | 0.81 | GPR119 (0.48) | LOXL2CA1CA2CA12CA9 | |
| SCHEMBL29003606 | 0.80 | LOXL2 (0.58) | LOXL2CYP4A11CYP4F2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250115684-A1 | Method for Preparing Polyethylene Polymerization Catalyst | SK INNOVATION CO., LTD. (KR) | 2025-04-10 | — | — | US | claimed |
| EP-4534571-A1 | METHOD FOR PREPARING POLYETHYLENE POLYMERIZATION CATALYST | SK Innovation Co., Ltd. (KR) | 2025-04-09 | — | — | EP | claimed |
| CN-119775460-A | Process for preparing polyethylene polymerization catalyst | SK新技术株式会社 | 2025-04-08 | — | — | CN | claimed |
| CN-118459780-A | Circular polarization luminescent material with in-situ adjustability and preparation method thereof | 苏州大学 | 2024-08-09 | — | — | CN | claimed |
| CN-115141117-A | Preparation and application of aggregation-induced luminescent material with mechanochromism and photochromism | 北京科技大学 | 2022-10-04 | — | — | CN | claimed |
| CN-216432339-U | A drying and dehumidifying device for production of methyl p-cyanobenzoate | 山东佰隆医药有限公司 | 2022-05-03 | — | — | CN | claimed |
| EP-3814355-B1 | TRIAZOLOTRIAZINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS | ZHEJIANG VIMGREEN PHARMACEUTICALS LTD (CN) | 2025-12-24 | — | — | EP | disclosed |
| US-20250195462-A1 | SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | MILESTONE PHARMACEUTICALS INC (CA) | 2025-06-19 | — | — | US | disclosed |
| US-12297178-B2 | Triazole derivative and use thereof | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2025-05-13 | — | — | US | disclosed |
| US-20250115684-A1 | Method for Preparing Polyethylene Polymerization Catalyst | SK INNOVATION CO., LTD. (KR) | 2025-04-10 | — | — | US | disclosed |
| EP-4534571-A1 | METHOD FOR PREPARING POLYETHYLENE POLYMERIZATION CATALYST | SK Innovation Co., Ltd. (KR) | 2025-04-09 | — | — | EP | disclosed |
| CN-119775460-A | Process for preparing polyethylene polymerization catalyst | SK新技术株式会社 | 2025-04-08 | — | — | CN | disclosed |
| US-20240366552-A1 | SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | MILESTONE PHARMACEUTICALS INC (CA) | 2024-11-07 | — | — | US | disclosed |
| US-5145854-A | 1-formyl-5,8,10-trideazafolates | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 1992-09-08 | — | — | US | disclosed |
| EP-0501876-A1 | N-(3-pyridylalkyl)sulfonamide derivative and pharmaceutical preparation containing thereof | TERUMO KABUSHIKI KAISHA (JP) | 1992-09-02 | — | — | EP | disclosed |
| US-5135949-A | Anticoagulants | BOEHRINGER MANNHEIM GMBH (DE) | 1992-08-04 | — | — | US | disclosed |
| US-4950732-A | RADIATION RESISTANCE | EASTMAN KODAK COMPANY | 1990-08-21 | — | — | US | disclosed |
| EP-0272692-A2 | Condensation copolymers containing bis-methine moieties and products therefrom | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-06-29 | — | — | EP | disclosed |
| US-4719203-A | CALCIUM METABOLISM DISORDERS | BOEHRINGER MANNHEIM GMBH (DE) | 1988-01-12 | — | — | US | disclosed |
| US-4598077-A | Amidine derivatives and cardiotonic compositions | TORII & CO. LTD. (JP) | 1986-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240366552-A1 | SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | ORAI1, ATP2A1, RYR2 | LOXL2 3496/4885CYP4A11 2712/4885CYP4F2 3383/4885 |
| US-12297178-B2 | Triazole derivative and use thereof | FABP4, LIPC, GPR119 | LOXL2 3840/4885CYP4A11 135/4885CYP4F2 1408/4885 |
| US-20250195462-A1 | SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF | ORAI1, ATP2A1, RYR2 | LOXL2 3496/4885CYP4A11 2712/4885CYP4F2 3383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.